빅테그라비르

3. 금기

빅테그라비르는 도페틸리드 및 리팜핀과 함께 사용해서는 안 된다.^[16]

3. 1. 약물 상호작용

4. 부작용

(내용 없음)

4. 1. 흔한 부작용

5. 사회와 문화

(내용 없음)

5. 1. 경제

참조

_[1] 저널 Recommended INN: List 75 https://www.who.int/[...] 2020-10-04
_[2] 웹사이트 Bictegravir - Gilead Sciences http://adisinsight.s[...] Springer Nature Switzerland AG 2017-01-22
_[3] 뉴스 New integrase inhibitor bictegravir looks promising in early studies http://www.aidsmap.c[...] 2017-01-20
_[4] 저널 Bictegravir, a novel integrase inhibitor for the treatment of HIV infection https://doi.org/10.1[...] 2023-08-28
_[5] 간행물 Gilead Presents Preliminary Data on Bictegravir, an Investigational Integrase Strand Transfer Inhibitor for the Treatment of HIV http://www.gilead.co[...] Gilead Sciences 2017-01-20
_[6] 웹사이트 Australian Public Assessment Report for Bictegravir / Emtricitabine / Tenofovir alafenamide https://www.tga.gov.[...] Therapeutic Goods Administration 2024-02-22
_[7] 웹사이트 Biktarvy https://www.ema.euro[...] European Medicines Agency 2024-02-22
_[8] 간행물 U.S. Food and Drug Administration Approves Gilead's Biktarvy (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV-1 Infection https://www.business[...] Gilead Sciences 2018-02-07
_[9] 웹사이트 BIKTARVY Data Sheet v 8.0 https://www.medsafe.[...] Medsafe 2024-02-22
_[10] 웹사이트 Bictegravir-emtricitabine-tenofovir alafenamide for the treatment of HIV-1 in adults https://www.england.[...] NHS England 2024-02-22
_[11] 간행물 Hetero launches TAFFIC, the latest 3-in-1 single pill for HIV treatment https://www.hetero.c[...] Hetero Drugs 2024-02-22
_[12] 웹사이트 Initial Regimens: ART-naïve Adults https://eacs.sanford[...] European AIDS Clinical Society 2024-02-22
_[13] 웹사이트 BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 (2023 interim update) https://www.bhiva.or[...] British HIV Association 2024-02-22
_[14] 웹사이트 Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV https://clinicalinfo[...] HIV.gov 2024-02-22
_[15] 저널 Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial https://pubmed.ncbi.[...] 2022-01-29
_[16] 웹사이트 Biktarvy - FDA Prescribing Highlights https://www.accessda[...] 2022-01-29
_[17] 간행물 GSK announces settlement between ViiV Healthcare and Gilead Sciences, Inc. resolving litigation relating to Biktarvy and ViiV's dolutegravir patents and entry into a patent licence agreement ViiV Healthcare 2023-08-26
_[18] 간행물 GSK announces settlement between ViiV Healthcare and Gilead Sciences, Inc. resolving litigation relating to Biktarvy and ViiV's dolutegravir patents and entry into a patent licence agreement https://us.gsk.com/e[...] 2023-08-28
_[19] 저널 Recommended INN: List 75 https://www.who.int/[...] 2016
_[20] 웹인용 Bictegravir - Gilead Sciences http://adisinsight.s[...] Springer Nature Switzerland AG 2017-01-22
_[21] 뉴스 New integrase inhibitor bictegravir looks promising in early studies http://www.aidsmap.c[...] 2016-07-06
_[22] 웹인용 'Press Release: Gilead Presents Preliminary Data on Bictegravir, an Investigational Integrase Strand Transfer Inhibitor for the Treatment of HIV {{!}} Gilead' http://www.gilead.co[...] Gilead 2016-06-20
_[23] 간행물 U.S. Food and Drug Administration Approves Gilead's Biktarvy (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV-1 Infection https://www.business[...] Gilead 2018-02-07